JANX008
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JANX008, covering 2025-10-14 to 2025-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies [Phase 1]